Keyur P. Patel
Active 2010–2025
- 167
- Papers
- 20,110
- Citations
- 76
- h-index
- 163
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine75.5%
- Biochemistry, Genetics and Molecular Biology18.8%
- Immunology and Microbiology2.8%
- Environmental Science0.8%
- Computer Science0.7%
- Engineering0.6%
- Other0.8%
Topics
- Acute Myeloid Leukemia Research15.8%
- Myeloproliferative Neoplasms: Diagnosis and Treatment5.8%
- Cancer Genomics and Diagnostics5.6%
- Chronic Myeloid Leukemia Treatments5.2%
- Acute Lymphoblastic Leukemia research4.3%
- Chronic Lymphocytic Leukemia Research3.4%
- Other59.9%
Coauthors
- Hagop M. Kantarjian95
- Farhad Ravandi79
- Guillermo Garcia‐Manero72
- Tapan M. Kadia72
- Elias Jabbour71
- Courtney D. DiNardo68
- Marina Konopleva59
- Naval Daver56
- Gautam Borthakur50
- Rashmi Kanagal‐Shamanna48
- Nicholas J. Short44
- Mark J. Routbort43
- Koichi Takahashi42
- Sanam Loghavi42
- Jörge E. Cortes40
- Rajyalakshmi Luthra40
- Koji Sasaki39
- L. Jeffrey Medeiros39
- Naveen Pemmaraju39
- Sherry Pierce39
- Ghayas C. Issa32
- Musa Yılmaz28
- Nitin Jain27
- Guillermo Montalban‐Bravo25
All papers
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Authors: Joseph D. Khoury, Éric Solary, Oussama Abla, Yassmine Akkari, Rita Alaggio, Jane F. Apperley, Rafael Bejar, Emilio Berti, Lambert Busque, John K. C. Chan, Weina Chen, Xueyan Chen, Wee Joo Chng, John Choi, Isabel Colmenero, Sarah E. Coupland, Nicholas C.P. Cross, Daphne de Jong, M. Tarek Elghetany, Emiko Takahashi, Jean‐François Emile, Judith A. Ferry, Linda Fogelstrand, Michaëla Fontenay, Ulrich Germing, Sumeet Gujral, Torsten Haferlach, Claire Harrison, Jennelle C. Hodge, Shimin Hu, Joop H. Jansen, Rashmi Kanagal‐Shamanna, Hagop M. Kantarjian, Christian P. Kratz, Xiaoqiu Li, Megan S. Lim, Keith R. Loeb, Sanam Loghavi, Andrea N. Marcogliese, Soheil Meshinchi, Phillip Michaels, Kikkeri N. Naresh, Yasodha Natkunam, Reza Nejati, German Ott, Eric Padron, Keyur P. Patel, Nikhil Patkar, Jennifer Picarsic, Uwe Platzbecker, Irene Roberts, Anna Schuh, William A. Sewell, Reiner Siebert, Prashant Tembhare, Jeffrey Tyner, Srđan Verstovšek, Wei Wang, Brent L. Wood, Wenbin Xiao, Cecilia C.S. Yeung, Andreas Hochhaus - Leukemia 2022 cited by 3,904
- Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
Authors: Courtney D. DiNardo, Ing Soo Tiong, Anna Quaglieri, Sarah MacRaild, Sanam Loghavi, Fiona C. Brown, Rachel Thijssen, Giovanna Pomilio, Adam Ivey, Jessica M. Salmon, Christina Glytsou, Shaun Fleming, Q. Zhang, Huaxian Ma, Keyur P. Patel, Steven M. Kornblau, Zhen Xu, Chong Chyn Chua, Xufeng Chen, Piers Blombery, Christoffer Flensburg, Nik Cummings, Iannis Aifantis, Hagop M. Kantarjian, David C.S. Huang, Andrew W. Roberts, Ian J. Majewski, Marina Konopleva, Andrew H. Wei - Blood 2020 cited by 649
- Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial
Authors: Elias Jabbour, Nicholas J. Short, Nitin Jain, Xuelin Huang, Guillermo Montalban‐Bravo, Pinaki P. Banerjee, Katayoun Rezvani, Xianli Jiang, Kun Hee Kim, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, Keyur P. Patel, Tapan M. Kadia, Naval Daver, Kelly S. Chien, Yesid Alvarado, Guillermo Garcia‐Manero, Ghayas C. Issa, Fadi Haddad, Monica Kwari, Jennifer Thankachan, Ricardo Delumpa, Walid Macaron, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M. Kantarjian - The Lancet Haematology 2022 cited by 239
- Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
Authors: Naval Daver, Guillermo Garcia‐Manero, Sreyashi Basu, Prajwal Boddu, Mansour Alfayez, Jörge E. Cortes, Marina Konopleva, Farhad Ravandi‐Kashani, Elias Jabbour, Tapan M. Kadia, Graciela M. Nogueras‐González, Jing Ning, Naveen Pemmaraju, Courtney D. DiNardo, Michael Andreeff, Sherry Pierce, Tauna Gordon, Steven M. Kornblau, Wilmer Flores, Zainab Alhamal, Carlos E. Bueso‐Ramos, Jeffrey L. Jorgensen, Keyur P. Patel, Jorge Blando, James P. Allison, Padmanee Sharma, Hagop M. Kantarjian - Cancer Discovery 2018 cited by 571
- Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
Authors: Kiyomi Morita, Feng Wang, Katharina Jahn, Tianyuan Hu, Tomoyuki Tanaka, Yuya Sasaki, Jack Kuipers, Sanam Loghavi, Sa A. Wang, Yuanqing Yan, Ken Furudate, Jairo Matthews, Latasha Little, Curtis Gumbs, Jianhua Zhang, Xingzhi Song, Erika J. Thompson, Keyur P. Patel, Carlos E. Bueso‐Ramos, Courtney D. DiNardo, Farhad Ravandi, Elias Jabbour, Michael Andreeff, Jörge E. Cortes, Kapil N. Bhalla, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Marina Konopleva, Daisuke Nakada, Nicholas E. Navin, Niko Beerenwinkel, P. Andrew Futreal, Koichi Takahashi - Nature Communications 2020 cited by 387
- Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Authors: Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, Courtney D. DiNardo, Lucy A. Godley, Ilaria Iacobucci, Siddhartha Jaiswal, Luca Malcovati, Alessandro M. Vannucchi, Keyur P. Patel, Daniel A. Arber, Maria E. Arcila, Rafael Bejar, Nancy Berliner, Michael J. Borowitz, Susan Branford, Anna Brown, Catherine Cargo, Hartmut Döhner, Brunangelo Falini, Guillermo Garcia‐Manero, Torsten Haferlach, Eva Hellström‐Lindberg, Annette S. Kim, Jeffery M. Klco, Rami S. Komrokji, Mignon Lee-Cheun Loh, Sanam Loghavi, Charles G. Mullighan, Seishi Ogawa, Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David M. Ross, Michael R. Savona, Akiko Shimamura, Radek C. Skoda, Françesc Solé, Richard M. Stone, Ayalew Tefferi, Matthew J. Walter, David Wu, Benjamin L. Ebert, Mario Cazzola - Blood 2022 cited by 208
- Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML
Authors: Nicholas J. Short, Naval Daver, Courtney D. DiNardo, Tapan M. Kadia, Lewis Nasr, Walid Macaron, Musa Yılmaz, Gautam Borthakur, Guillermo Montalban‐Bravo, Guillermo Garcia‐Manero, Ghayas C. Issa, Kelly S. Chien, Elias Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J. Stojanik, Keyur P. Patel, Regina Abramova, Jennifer Thankachan, Marina Konopleva, Hagop M. Kantarjian, Farhad Ravandi - Journal of Clinical Oncology 2024 cited by 146
- Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
Authors: Koichi Takahashi, Feng Wang, Hagop M. Kantarjian, Doss Denaha, Kanhav Khanna, Erika J. Thompson, Li Zhao, Keyur P. Patel, Sattva S. Neelapu, Curtis Gumbs, Carlos E. Bueso‐Ramos, Courtney D. DiNardo, Simona Colla, Farhad Ravandi, Jianhua Zhang, Xuelin Huang, Xifeng Wu, Felipe Samaniego, Guillermo Garcia‐Manero, P. Andrew Futreal - The Lancet Oncology 2016 cited by 400
- Ibrutinib and Venetoclax for First-Line Treatment of CLL
Authors: Nitin Jain, Michael J. Keating, Philip A. Thompson, Alessandra Ferrajoli, Jan A. Burger, Gautam Borthakur, Koichi Takahashi, Zeev Estrov, Nathan Fowler, Tapan M. Kadia, Marina Konopleva, Yesid Alvarado, Musa Yılmaz, Courtney D. DiNardo, Prithviraj Bose, Maro Ohanian, Naveen Pemmaraju, Elias Jabbour, Koji Sasaki, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Jeffrey L. Jorgensen, Naveen Garg, Xuemei Wang, Katrina Sondermann, Nichole Cruz, Chongjuan Wei, Ana Ayala, William Plunkett, Hagop M. Kantarjian, Varsha Gandhi, William G. Wierda - New England Journal of Medicine 2019 cited by 504
- High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse
Authors: Nicholas J. Short, Hagop Kantarjian, Farhad Ravandi, Marina Konopleva, Nitin Jain, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Walid Macaron, Tapan M. Kadia, Sa A. Wang, Jeffrey L. Jorgensen, Joseph D. Khoury, Musa Yılmaz, Partow Kebriaei, Koichi Takahashi, Guillermo Garcia‐Manero, Naval Daver, Sean M. Post, Xuelin Huang, Steven M. Kornblau, S. Pelletier, Wilmer Flores, Jairo Matthews, Rebecca Garris, Elias Jabbour - Blood Advances 2022 cited by 112
- Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults
Authors: Nitin Jain, Kathryn G. Roberts, Elias Jabbour, Keyur P. Patel, Agda Karina Eterovic, Ken Chen, Patrick A. Zweidler‐McKay, Xinyan Lu, Gloria L. Fawcett, Sa A. Wang, Sergej Konoplev, Richard C. Harvey, I‐Ming Chen, Debbie Payne-Turner, Marcus Valentine, Deborah A. Thomas, Guillermo Garcia‐Manero, Farhad Ravandi, Jörge E. Cortes, Steven M. Kornblau, Susan O’Brien, Sherry Pierce, Jeffrey L. Jorgensen, Kenna Shaw, Cheryl L. Willman, Charles G. Mullighan, Hagop M. Kantarjian, Marina Konopleva - Blood 2016 cited by 386
- Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia
Authors: Nicholas J. Short, Guillermo Montalban‐Bravo, Hyunsoo Hwang, Jing Ning, Miguel Franquiz, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Courtney D. DiNardo, Farhad Ravandi, Guillermo Garcia‐Manero, Koichi Takahashi, Marina Konopleva, Naval Daver, Ghayas C. Issa, Michael Andreeff, Hagop M. Kantarjian, Tapan M. Kadia - Blood Advances 2020 cited by 181
- Ultrasensitive NGS MRD assessment in Ph+ ALL : Prognostic impact and correlation with RT‐PCR for BCR::ABL1
Authors: Nicholas J. Short, Elias Jabbour, Walid Macaron, Farhad Ravandi, Nitin Jain, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Sanam Loghavi, Fadi Haddad, Musa Yılmaz, Ghayas C. Issa, Partow Kebriaei, Steven M. Kornblau, Sarah Pelletier, Wilmer Flores, Jairo Matthews, Rebecca Garris, Hagop M. Kantarjian - American Journal of Hematology 2023 cited by 73
- Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements
Authors: Ghayas C. Issa, Jabra Zarka, Koji Sasaki, Wei Qiao, Daewoo Pak, Jing Ning, Nicholas J. Short, Fadi Haddad, Zhenya Tang, Keyur P. Patel, Branko Cuglievan, Naval Daver, Courtney D. DiNardo, Elias Jabbour, Tapan M. Kadia, Gautam Borthakur, Guillermo Garcia‐Manero, Marina Konopleva, Michael Andreeff, Hagop M. Kantarjian, Farhad Ravandi - Blood Cancer Journal 2021 cited by 99
- Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial
Authors: Elias Jabbour, Nicholas J. Short, Nitin Jain, Philip A. Thompson, Tapan M. Kadia, Alessandra Ferrajoli, Xuelin Huang, Musa Yılmaz, Yesid Alvarado, Keyur P. Patel, Guillermo Garcia‐Manero, Walid Macaron, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M. Kantarjian - The Lancet Haematology 2022 cited by 82
- Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia
Authors: Jayastu Senapati, Samuel Urrutia, Sanam Loghavi, Nicholas J. Short, Ghayas C. Issa, Abhishek Maiti, Hussein A. Abbas, Naval Daver, Naveen Pemmaraju, Sherry Pierce, Kelly S. Chien, Koji Sasaki, Tapan M. Kadia, Danielle Hammond, Gautam Borthakur, Keyur P. Patel, Farhad Ravandi, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Courtney D. DiNardo - Blood 2023 cited by 61
- Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML
Authors: Courtney D. DiNardo, Farhad Ravandi, Sam Agresta, Marina Konopleva, Koichi Takahashi, Tapan M. Kadia, Mark J. Routbort, Keyur P. Patel, Mark Brandt, Sherry Pierce, Guillermo Garcia‐Manero, Jörge E. Cortes, Hagop M. Kantarjian - American Journal of Hematology 2015 cited by 315
- Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
Authors: Feng Wang, Kiyomi Morita, Courtney D. DiNardo, Ken Furudate, Tomoyuki Tanaka, Yuanqing Yan, Keyur P. Patel, Kyle J. MacBeth, Bin Wu, Guowen Liu, Mark G. Frattini, Jairo Matthews, Latasha Little, Curtis Gumbs, Xingzhi Song, Jianhua Zhang, Erika J. Thompson, Tapan M. Kadia, Guillermo Garcia‐Manero, Elias Jabbour, Farhad Ravandi, Kapil N. Bhalla, Marina Konopleva, Hagop M. Kantarjian, P. Andrew Futreal, Koichi Takahashi - Nature Communications 2021 cited by 115
- Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML
Authors: Ghayas C. Issa, Aram Bidikian, Sangeetha Venugopal, Marina Konopleva, Courtney D. DiNardo, Tapan M. Kadia, Gautam Borthakur, Elias Jabbour, Naveen Pemmaraju, Musa Yılmaz, Nicholas J. Short, Abhishek Maiti, Koji Sasaki, Lucia Masárová, Sherry Pierce, Koichi Takahashi, Guilin Tang, Sanam Loghavi, Keyur P. Patel, Michael Andreeff, Kapil N. Bhalla, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop M. Kantarjian, Naval Daver - Blood Advances 2022 cited by 56
- Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab
Authors: Yasmin Abaza, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Elihu H. Estey, Gautam Borthakur, Elias Jabbour, Stefan Faderl, Susan O’Brien, William G. Wierda, Sherry Pierce, Mark Brandt, Deborah McCue, Rajyalakshmi Luthra, Keyur P. Patel, Steven M. Kornblau, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Nitin Jain, Srđan Verstovšek, Alessandra Ferrajoli, Michael Andreeff, Marina Konopleva, Zeev Estrov, Maria Cielo Foudray, David McCue, Jörge E. Cortes, Farhad Ravandi - Blood 2016 cited by 297
- Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia
Authors: Nicholas J. Short, Elias Jabbour, Koji Sasaki, Keyur P. Patel, Susan O’Brien, Jörge E. Cortes, Rebecca Garris, Ghayas C. Issa, Guillermo Garcia‐Manero, Rajyalakshmi Luthra, Deborah A. Thomas, Hagop M. Kantarjian, Farhad Ravandi - Blood 2016 cited by 253
- Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens
Authors: Curtis A. Lachowiez, Sanam Loghavi, Tapan M. Kadia, Naval Daver, Gautam Borthakur, Naveen Pemmaraju, Kiran Naqvi, Yesid Alvarado, Musa Yılmaz, Nicholas J. Short, Maro Ohanian, Sherry R. Pierce, Keyur P. Patel, Wei Qiao, Jing Ning, Koji Sasaki, Koichi Takahashi, Elias Jabbour, Michael Andreeff, Farhad Ravandi, Hagop M. Kantarjian, Marina Konopleva, Courtney D. DiNardo - Blood Advances 2020 cited by 156
- Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 Inhibitors
Authors: Ahmad S. Alotaibi, Musa Yılmaz, Rashmi Kanagal‐Shamanna, Sanam Loghavi, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur, Marina Konopleva, Sherry Pierce, Sa A. Wang, Guilin Tang, Veronica Guerra, Bachar Samra, Naveen Pemmaraju, Elias Jabbour, Nicholas J. Short, Ghayas C. Issa, Maro Ohanian, Guillermo Garcia‐Manero, Kapil N. Bhalla, Keyur P. Patel, Koichi Takahashi, Michael Andreeff, Jörge E. Cortes, Hagop M. Kantarjian, Farhad Ravandi, Naval Daver - Blood Cancer Discovery 2020 cited by 97
- Hypomethylating agent and venetoclax with FLT3 inhibitor “triplet” therapy in older/unfit patients with FLT3 mutated AML
Authors: Musa Yılmaz, Hagop M. Kantarjian, Nicholas J. Short, Patrick K. Reville, Marina Konopleva, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur, Naveen Pemmaraju, Abhishek Maiti, Elias Jabbour, Nitin Jain, Ghayas C. Issa, Koichi Takahashi, Koji Sasaki, Maro Ohanian, Sherry Pierce, Guilin Tang, Sanam Loghavi, Keyur P. Patel, Sa A. Wang, Guillermo Garcia‐Manero, Michael Andreeff, Farhad Ravandi, Naval Daver - Blood Cancer Journal 2022 cited by 64
